Intravenous Infusions (XGHA:IIL) Cash-to-Debt : 0.00 (As of . 20)

View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Intravenous Infusions's cash to debt ratio for the quarter that ended in . 20 was 0.00.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Intravenous Infusions couldn't pay off its debt using the cash in hand for the quarter that ended in . 20.

The historical rank and industry rank for Intravenous Infusions's Cash-to-Debt or its related term are showing as below:

XGHA:IIL's Cash-to-Debt is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 1.025
* Ranked among companies with meaningful Cash-to-Debt only.

Intravenous Infusions Cash-to-Debt Historical Data

The historical data trend for Intravenous Infusions's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Intravenous Infusions Cash-to-Debt Chart

Intravenous Infusions Annual Data

Trend

Cash-to-Debt

Intravenous Infusions Semi-Annual Data

Cash-to-Debt

Competitive Comparison of Intravenous Infusions's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Intravenous Infusions's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intravenous Infusions's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intravenous Infusions's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Intravenous Infusions's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

Intravenous Infusions Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Intravenous Infusions's Cash to Debt Ratio for the fiscal year that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Intravenous Infusions's Cash to Debt Ratio for the quarter that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Intravenous Infusions (XGHA:IIL) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Intravenous Infusions Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Intravenous Infusions Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA

Website

https://www.iil.com.gh

Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.